12 results
10-KT
RCEL
AVITA Medical Inc
28 Feb 22
Annual report (with FYE transition)
4:11pm
limitations may hinder our ability to recoup our total investment in our RECELL System or other future products, even after obtaining regulatory approval
10-K
2020 FY
RCEL
AVITA Medical Inc
27 Aug 20
Annual report
12:00am
impact the revenue we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup
6-K
EX-99.2
RCEL
AVITA Medical Inc
12 May 20
Current report (foreign)
11:00am
of the product in that country; or
hinder the Company’s ability to recoup its total investment in the product or other future products.
If the Company
20-F
0t28telmi7vs
31 Oct 19
Annual report (foreign)
3:49pm
20FR12B/A
reqgixeb989pt1p25ls1
27 Sep 19
Initial registration of securities (foreign private issuers) (amended)
4:13pm
20FR12B/A
56x3va
25 Sep 19
Initial registration of securities (foreign private issuers) (amended)
6:07am
20FR12B
4z0p bdwt
19 Sep 19
Initial registration of securities (foreign private issuers)
4:43pm
DRS/A
vz2 0sc0j1gglp3zxt6
11 Sep 19
Draft registration statement (amended)
12:00am
DRS/A
ljaqmn6vz34ra yl2cku
23 Aug 19
Draft registration statement (amended)
12:00am
DRS
42rq8
19 Jul 19
Draft registration statement
12:00am
- Prev
- 1
- Next